NCT03485274View on ClinicalTrials.gov

Substance Misuse To Psychiatric Disorders for Cannabis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

July 25, 2018

Primary Completion Date

February 28, 2023

Study Completion Date

April 30, 2023

Conditions
Cannabis Use DisorderDepressive StateAnxiety StateDepressionAnxiety DisordersPharmacotherapy
Interventions
DRUG

Vortioxetine

oral medication taken once daily

OTHER

Treatment as Usual

Any pharmacological or non-pharmacotherapy modalities other than use of vortioxetine

Trial Locations (1)

000000

Queen Mary Hospital, Hong Kong

All Listed Sponsors
collaborator

Queen Mary Hospital, Hong Kong

OTHER

lead

The University of Hong Kong

OTHER

NCT03485274 - Substance Misuse To Psychiatric Disorders for Cannabis | Biotech Hunter | Biotech Hunter